• Abortion pill access scuffles: 5 recent updates

    After the FDA allowed some retail pharmacies to dispense medication abortion pill mifepristone and CVS and Walgreens said they're filling out the application, multiple states are either further restricting or expanding access. 
  • HIV vaccine trial halted after phase 3 failure

    An HIV vaccine candidate failed to prove efficacy in a phase 3 trial, and it's now abandoned, according to Janssen, Johnson & Johnson's pharmaceutical arm. 
  • Local anesthetic drug supply: 132 in shortage, 13 available

    Between two types of local anesthetics, there are 132 in short supply and 13 available, according to the American Society of Health-System Pharmacists. 
  • 10 systems seeking pharmacy leaders

    The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.
  • U of Hawaii pharmacy dean wins leadership award

    Miriam Mobley Smith, PharmD, the interim dean of the University of Hawai'i at Hilo's pharmacy college, won the American Society of Health-System Pharmacists' distinguished leadership award.
  • Moderna's RSV shot 83.7% effective, late-stage trial shows

    Moderna's respiratory syncytial virus vaccine candidate for older adults is about 84 percent effective, its phase 3 study showed, and the company said it will seek approval this year. 
  • When it comes to drugs and TV ads, there is reason for skepticism: study

    About 73 percent of the drugs advertised on television have "low therapeutic value" as compared with existing, efficacious medications, according to a study published Jan. 13 in JAMA Open Network.
  • Florida warns pharmacies against distributing abortion pills

    The Florida Agency for Healthcare Administration warned pharmacies not to dispense abortion pills in light of the FDA's approval for pharmacies to do so in states where it is allowed, the Union-Bulletin reported Jan. 15.
  • Georgia hospital opens pharmacy

    Brunswick, Ga.-based Coastal Community Health opened its pharmacy after a year of expansions, The Brunswick News reported Jan. 16. 
  • Bivalent boosters not linked to stroke risk, federal agencies say

    Pfizer's updated COVID-19 booster does not increase the risk for ischemic stroke in patients 65 and older, according to a CDC and FDA review of multiple studies, reporting databases and other countries. 
  • 6 drugmakers are short on heparin

    Six drugmakers are reporting shortages of heparin, a blood thinner, and 19 solutions are back ordered for weeks, according to the American Society of Health-System Pharmacists. 
  • Walmart opens HIV-focused specialty pharmacy in New Jersey

    Walmart opened an HIV-focused specialty pharmacy in Hudson County, N.J., News12 New Jersey reported Jan. 14.
  • Paxlovid underprescribed for older adults, physician survey finds

    Physicians are hesitant to prescribe Paxlovid, a COVID-19 antiviral, to patients 65 and older mostly because of drug interaction worries, according to a survey conducted by Medscape. 
  • 21 flu drugs in shortage, most with no resupply date

    Eight drugmakers together have 21 oseltamivir presentations — a common flu drug sold under the brand name Tamiflu — on back order and allocation, and most cannot estimate a resupply date, according to the American Society of Health-System Pharmacists. 
  • 4 legislators prod J&J for answers over Tylenol, Motrin shortages

    As the shortage of children's pain medications continues, four Massachusetts lawmakers questioned Johnson & Johnson, the largest U.S. pharmaceutical company by revenue, about its supply of Tylenol and Motrin in a letter sent Jan. 12. 
  • FDA approves 1st combined asthma drug for adults

    The FDA approved Airsupra, the first asthma drug combination of an inhaled corticosteroid and a short-acting beta-agonist, Jan. 11. 
  • 2022 below annual average of novel drug approvals: 5 report notes

    The FDA approved 37 novel drugs in 2022 — the third lowest number since 2013 — according to a Jan. 10 agency report.  
  • Mark Cuban's pharmacy partners with 3rd PBM

    Mark Cuban Cost Plus Drugs Co. and pharmacy benefit manager RxPreferred Benefits partnered to bring Mr. Cuban's online pharmacy to employers and their members part of the PBM, the two companies said Jan. 11. 
  • Colorado considers capping cost of EpiPens

    Colorado lawmakers are floating a bill to cap the cost of epinephrine autoinjectors, commonly known as EpiPens, Colorado Public Radio reported Jan. 11. 
  • 10 systems seeking pharmacy leaders

    The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

Featured Whitepapers

Featured Webinars